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Abstract: Enterotoxaemia is a disease with a high associated mortality rate, affecting beef 
and veal calves worldwide, caused by C. perfringens alpha toxin and perfringolysin.  
A longitudinal study was conducted to determine the dynamics of antibodies against these 
toxins in 528 calves on 4 beef and 15 veal farms. The second study aimed to determine the 
effect of solid feed intake on the production of antibodies against alpha toxin and 
perfringolysin. The control group only received milk replacer, whereas in the test group solid 
feed was provided. Maternal antibodies for alpha toxin were present in 45% of the veal calves 
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and 66% of the beef calves. In beef calves a fluent transition from maternal to active immunity 
was observed for alpha toxin, whereas almost no veal calves developed active immunity. 
Perfringolysin antibodies significantly declined both in veal and beef calves. In the second 
study all calves were seropositive for alpha toxin throughout the experiment and solid feed 
intake did not alter the dynamics of alpha and perfringolysin antibodies. In conclusion, the 
present study showed that veal calves on a traditional milk replacer diet had significantly lower 
alpha toxin antibodies compared to beef calves in the risk period for enterotoxaemia, whereas 
no differences were noticed for perfringolysin. 
Keywords: alpha toxin; antibodies; Clostridium perfringens; enterotoxaemia; 
perfringolysin; veal 
 
1. Introduction 
Enterotoxaemia is a fatal disease of young cattle, particularly in intensive production systems, and 
may be characterized by sudden death and necro-haemorrhagic enteritis [1]. The pathogenesis of 
enterotoxaemia in calves has long been unclear. Recently, Clostridium perfringens alpha toxin and 
perfringolysin have been identified as the key virulence factors involved in the development of bovine 
necro-haemorrhagic enteritis [2]. 
Belgian Blue (BB) calves are predisposed to enterotoxaemia. In BB veal calves up to 20% of the 
total mortality, especially in the last weeks before slaughter, can be attributed to enterotoxaemia, 
whereas in Holstein Friesian (HF) or crossbred veal calves the incidence is significantly lower [3,4]. 
High mortality rates due to enterotoxaemia have also been reported in suckler calves, whereas 
enterotoxaemia is less frequent in beef production systems with immediate separation from the  
dam [5–7]. In addition to a possible genetic predisposition, the differences in diet between veal and 
beef calves might play a role [8]. Whereas veal calves are mainly raised on milk replacer and receive 
only limited amounts of solid feed, beef calves are fed a limited amount of milk replacer, are weaned 
at an early age, and thereafter predominantly fed with solid feeds [9,10]. Similar to other animal 
species, the rich diet of veal calves has been implicated in predisposition to enterotoxaemia, but there 
is no scientific evidence for this statement [11–13]. 
In other clostridial diseases, maternal immunity against exotoxines is generally protective [14].  
In calves, experimental studies have shown maternal antibodies against C. perfringens epsilon and 
alpha toxin are detectable up to 200 days after birth [15,16]. To date no information on maternal 
antibody decline and acquisition of active immunity against alpha toxin and perfringolysin in calves is 
available. Such information may help to elucidate the epidemiology of bovine enterotoxaemia and is of 
crucial importance for the development of alpha toxin and perfringolysin vaccination schemes in  
the field. We hypothesized that these antibody dynamics differ between breeds and production 
systems, thereby partially explaining differences in susceptibility for enterotoxaemia. 
Therefore the first objective of the present study was to determine antibody dynamics in beef calves 
and veal calves of different breeds. The second objective was to determine the effect of solid feed 
intake on the production of alpha toxin and perfringolysin antibodies in veal calves. 
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2. Results and Discussion 
2.1. Study 1: Antibody Dynamics against Alpha Toxin and Perfringolysin in Veal and Beef Calves 
2.1.1. Alpha Toxin Antibody Dynamics 
Figure 1 and Table 1 give an overview of the mean inhibition of the optical density (OD) and  
Table 1 of the prevalence of C. perfringens alpha toxin antibodies in the different groups at the 
different ages. At the age of two weeks, the seroprevalence of alpha toxin was 45% and 66% in veal 
and conventional BB respectively. This difference was not significant. In beef calves, a smooth 
transition from maternal to actively produced alpha toxin antibodies was noted with no significant 
differences between the different ages. In contrast, veal calves demonstrated a significant decline in 
alpha toxin antibodies between the ages of two and eight weeks as well as between the ages of 8 and 
14 weeks. Only 5% ± 4% of the veal calves seroconverted for alpha toxin over the course of this study.  
The difference between subjects (production system beef vs. veal) was significant at every time point 
(p < 0.001). At the age of 26 weeks, the percentage of animals with alpha toxin antibodies was 
significantly higher in beef (85%) than in veal calves (16%). 
Within the group of veal calves, there was no overall significant effect of breed on % inhibition of OD. 
At the age of 8 and 14 weeks crossbred calves had significantly higher % inhibition of OD  
(more antibodies) than HF calves (p < 0.01). 
 
Figure 1. Results of the Clostridium perfringens alpha toxin antibody blocking ELISA in 
study 1, presented as the mean percentage inhibition of the OD for veal and beef calves at 
every sampled age. 
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Table 1. Results of the C. perfringens alpha toxin antibody blocking ELISA. 
Alpha toxin blocking ELISA 
Mean % Inhibition of OD ± Standard Deviation Seroprevalence ± Standard Deviation 
Age (in weeks) Age (in weeks) 
Populations  n 2 8 14 26 2 8 14 26 
Veal total 443 a43 ± 21 b35 ± 17 c30 ± 15 c30 ± 15 46 ± 13 29 ± 14 17 ± 13 16 ± 9 
Veal cross 167 a45 ± 22 b40 ± 18 c35 ± 15 c33 ± 15 49 ± 18 45 ± 11 28 ± 12 20 ± 12 
Veal HF 121 a40 ± 21 b29 ± 12 b23 ± 10 b29 ± 17 43 ± 10 17 ± 4 6 ± 10 17 ± 8 
Veal BB 155 a42 * ± 20 b34 * ± 17 c29 * ± 24 c26 * ± 13 45 ± 13 26 ± 10 16 ± 4 9 ± 6 
Beef BB 85 a51 * ± 23 a52 * ± 16 a55 * ± 13 a53 * ± 12 66 ± 40 76 ± 28 91 ± 8 85 ± 14 
All calves 528 a44 ± 21 b37 ± 18 b32 ± 16 b33 ± 17 44 ± 22 37 ± 18 32 ± 16 33 ± 17 
BB: Belgian Blue; HF: Holstein Friesian; cross: crossbred; Remarks: Statistic analyses were performed on the Mean % 
inhibition of OD. Values indicated with * are significantly different (p < 0.05) between veal and beef Belgian Blue calves at a 
given time point. Within subjects effect was significant in the veal groups. Values with a different letter (a,b,c) are significantly 
different (p < 0.05). 
2.1.2. Perfringolysin Antibody Dynamics 
Results are summarized in Figure 2. Perfringolysin antibodies decreased significantly between two and 
eight weeks of age (p < 0.01) in veal calves and between 2 and 14 weeks of age in beef calves. Veal calves 
had significantly higher perfringolysin antibody titers than beef calves at the age of eight weeks and at the 
age of 26 weeks (p < 0.01). 
 
Figure 2. Clostridium perfringens perfringolysin antibody dynamics in 153 Belgian blue 
veal and 84 beef calves. Values indicated with * are significantly different (p < 0.05) 
between veal and beef at a given time point. Within subjects effect was significant in the 
veal group. Values with a different letter are significantly different within the test group 
(veal or beef) (p < 0.05). Error bars represent standard error of the mean. 
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2.2. Study 2: Effect of Solid Feed Provision on Alpha Toxin and Perfringolysin Antibody Dynamics 
2.2.1. Mortality, Incidence of Enterotoxaemia and Average Weight Gain 
There was no morbidity during the trial, so no calves had to be excluded from the experiments; nor 
were there any fatalities or enterotoxaemia cases. 
Average body weight at two weeks of age was 53 ± 6 kg in group 1 and 52 ± 3 kg in group 2.  
Average daily gain was significantly higher in the calves that received solid feed (836 ± 118 g vs.  
1002 ± 120 g; p < 0.05, two way ANOVA). 
2.2.2. Alpha Toxin and Perfringolysin Antibody Dynamics 
There were no significant differences in alpha toxin or perfringolysin antibody levels between the 
groups (Table 2 and Figure 3). For alpha toxin, antibodies were high in both groups during the whole 
trial and the overall seroprevalence was 100%. For perfringolysin, there was a significant decrease in 
antibody titers between two weeks and eight weeks of age in both groups (p < 0.05). 
Table 2. Results of study 2: effect of solid feed provision. 
Alpha Toxin Serology (% Inhibition of OD ± Standard Deviation) 
Group  Age in Weeks 2 8 14 26 
Group 1 72 ± 14 67 ± 11 67 ± 8 70 ± 5 
Group 2 64 ± 13 66 ± 8 68 ± 6 67 ± 5 
Total 68 ± 14 66 ± 10 68 ± 7 69 ± 5 
All calves were Holstein Friesian male veal calves. Group 1 (n = 15) was fed with only milk replacer, while 
group 2 (n = 15) received milk replacer and solid feed. There were no significant differences between groups 
or within a group between time points. 
 
Figure 3. Dynamics of Clostridium perfringens’ perfringolysin antibody titers for Holstein 
Friesian veal calves fed only with milk replacer or with milk replacer and solid feed.  
Error bars represent standard error of the mean. 
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2.3. Discussion 
To be able to protect calves from enterotoxaemia by vaccination, it is crucial to obtain insights in 
the presence and decline of maternal antibodies against the toxins included in the vaccine [14].  
In this study, maternal antibodies against alpha toxin were common in calves destined for beef and 
veal production, as has also been described for epsilon toxin in goats [14]. In veal calves, there was a 
significant decrease in antibodies against alpha toxin until the age of 14 weeks and the antibody levels 
remained low until the end of the study when the calves were 26 weeks of age. At the age of 14 weeks, 
only 17% of the veal calves were seropositive for alpha toxin, possibly indicating that, from that moment 
on, the majority of these animals could have been vaccinated with alpha toxin-based vaccines without 
interference with maternally derived antibodies. Since in veal calves, enterotoxaemia mainly occurs 
from the age of 20 weeks onward, it might be possible to immunize them prior to the period of greatest 
risk, using such vaccines. Further studies, including field trials and protection studies in experimentally 
infected calves are, however, necessary to try and develop effective vaccination schedules. 
We hypothesized that differences exist between veal and beef calves in dynamics of alpha toxin and 
perfringolysin antibodies, which might help to explain the higher incidence of enterotoxaemia in veal 
calves [4]. This hypothesis was confirmed for alpha toxin. Indeed, only 5% of the veal calves, raised 
with the traditional all-liquid diet, seroconverted for alpha toxin and at the age of 26 weeks, only 16% 
of the veal calves were seropositive for alpha toxin, as opposed to 85% of the beef calves. Based on the 
absence of a breed effect within the same nutritional management (=veal), it was hypothesized that the 
predisposition of veal calves might be associated with the diet rather than the breed. One possible 
explanation might be the effect of the diet on the production of alpha toxin by C. perfringens in the 
gastro-intestinal tract. Prolonged production of low amounts of toxin in the gastro-intestinal might be 
influenced by dietary factors and may lead to seroconversion and possibly protection against 
enterotoxaemia. This has also been suggested for acquisition of antibodies against tetanus toxin and  
C. perfringens epsilon toxin [14,17–21]. 
Our hypothesis was not confirmed for perfringolysin antibodies, since at the ages of 8 and 26 weeks, 
veal calves had significantly higher antibody titers against this toxin than beef calves. It has been 
shown that alpha toxin and perfringolysin act synergistically in the development of necrohemorrhagic 
enteritis in a calf intestinal loop model, possibly by targeting the endothelial cells [2]. The relative 
importance of antibodies against both toxins in protection requires further studies. 
Since the most striking difference between the diet in veal and beef calves is the availability of large 
amounts of solid feed, we studied the influence of solid feed provision. Unfortunately, we encountered 
several unexpected observations which made the interpretation of this trial more difficult. First, using 
the same ELISA, all of the studied calves had high levels of alpha toxin antibodies at the age of  
two weeks, in contrast to the field observations made between 2009 and 2011. A straightforward 
explanation was not found. It is possible that differences in colostrum provision or in the vaccination 
status of the dams may have played a role. Secondly, in contrast to the first study, the veal calves on 
the all-liquid diet produced alpha toxin antibodies. Differences in milk replacer composition may help 
to explain this observation. At the time of the first study (2009–2011), veal calves were predominantly 
fed with high amounts of highly concentrated milk replacer. The second study was conducted five 
years later, and alternative feeding regimes claiming improved animal welfare had then become 
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common practice in the local veal industry. The current milk replacers, including the product used in 
our second study, contain lower concentrations of whey proteins than milk replacers generally used at 
the time of our first field study in veal calves. Moreover, the current feeding regimes also provide 
lower amounts of milk replacer compared to the previous regimes. Contact with milk protein has been 
observed to decrease alpha toxin production by C. perfringens, which may influence antibody 
production against this toxin ([22], confirmed by unpublished data in supplementary materials). Since 
the provision of solid feed did not influence the antibody dynamics of C. perfringens alpha toxin and 
perfringolysin, differences in quantity and quality of milk replacer used in veal calves compared to 
beef calves might lead to different exposure to alpha toxin, possibly explaining the difference in 
antibody production observed in both studies. Further research is required to unravel the dietary risk 
factors for enterotoxaemia (quantity, concentration and composition of both milk replacer and solid 
feed), in order to be able to prevent the disease through nutritional management. 
3. Experimental Section 
All experiments were conducted with permission of the local ethical committee (EC2012/118 and 
EC2014/016). 
3.1. Study 1: Dynamics of Antibodies against Alpha Toxin and Perfringolysin in Veal and Beef Calves 
A prospective longitudinal cohort study was conducted to determine the effect of production 
systems (veal or beef) on the alpha toxin and perfringolysin antibody dynamics and of breed on the 
alpha toxin antibody dynamics in veal calves. 
3.1.1. Animals 
The study was conducted in 528 animals, housed on 19 conveniently selected farms (15 veal farms,  
5 BB, 5 Holstein Friesian (HF), 5 crossbred (HFxBB)) and four beef farms (4 BB) (Table 3). Veal calves 
were sampled between October 2007 and October 2009, and beef calves were sampled between November 
2013 and August 2014. Veal calves received a commercial all liquid diet, with minimal amounts of solid 
feed (<200 g/day). On the conventional BB farms calves were weaned between 14 and 26 weeks of age. 
Details on the rations and housing conditions in veal and beef farms are provided in Table 3. None of the 
farms had a history of vaccination against enterotoxaemia. On the beef farms, calves received colostrum 
from unvaccinated dams. For the veal farms, vaccination history of the dams was unknown. 
Beef calves were weaned (deprived of milk replacer) at the age of about 12 weeks, whereas veal 
calves received the milk replacer throughout the study. 
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Table 3. Housing conditions and feeding regime of the herds included in the first study on 
antibody dynamics of C. perfringens alpha toxin and perfringolysin. 
Herd 
Number of 
Calves in Study 
Production 
System 
Breed Floor 
Feed 
Milk Replacer 
% NP % SMP Weaning Solid Feed  
1 25 Veal HF Slatted floor 95 5 No <200 g/d 
2 25 Veal HF Slatted floor 95 5 No <200 g/d 
3 25 Veal HFXBB Slatted floor 95 5 No <200 g/d 
4 25 Veal BB Slatted floor 30 70 No <200 g/d 
5 25 Veal HFXBB Slatted floor 95 5 No <200 g/d 
6 25 Veal BB Slatted floor 30 70 No <200 g/d 
7 25 Veal HF Slatted floor 95 5 No <200 g/d 
8 26 Veal HF Slatted floor 95 5 No <200 g/d 
9 25 Veal HF Slatted floor 95 5 No <200 g/d 
10 24 Veal BB Slatted floor 30 70 No <200 g/d 
11 30 Veal BB Slatted floor 30 70 No <200 g/d 
12 39 Veal HFXBB Slatted floor 95 5 No <200 g/d 
13 38 Veal BB Slatted floor 30 70 No <200 g/d 
14 41 Veal HFXBB Slatted floor 95 5 No <200 g/d 
15 39 Veal HFXBB Slatted floor 95 5 No <200 g/d 
16 21 Beef BB Straw bedded 0 100 Yes Ad lib 
17 20 Beef BB Straw bedded 0 100 Yes Ad lib 
18 27 Beef BB Straw bedded 0 100 Yes Ad lib 
19 23 Beef BB Straw bedded 0 100 Yes Ad lib 
BB: Belgian Blue; HF: Holstein Friesian; HFXBB: Crossbred calves; SMP: Milk replacer containing whey 
powder and skimmed milk powder; NP: Nill product (Milk replacer based on whey powder, without 
skimmed milk powder, casein fraction replaced by vegetable protein); Ad lib: unrestrained provision. 
3.1.2. Sampling 
Serum samples were taken from the jugular vein from all calves at the age of 2, 8, 14 and 26 weeks. 
All serum samples were kept frozen (−18 °C) until analysis. 
3.1.3. Antibody Determination 
Alpha Toxin Antibody ELISA 
A commercial serum blocking Elisa kit for C. perfringens alpha toxin (BIO K 291, Bio-X, Jemelle, 
Belgium) was used according to the manufacturer’s guidelines. The percentage inhibition for a sample 
was calculated by the following formula: 
% inhibition sample = [(OD neg – OD sample)/OD neg] × 100 (1)
A calf was considered seropositive if the inhibition percentage was higher than 40%. A calf was 
considered to have seroconverted if the inhibition persentage increased with 40% of more in 
consecutive sampling points. 
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Expression and Purification of Perfringolysin 
The pTrcHisA plasmids encoding native perfringolysin (Department of Microbiology and 
Immunology, College of Medicine, University of Oklahoma, USA) were transformed in chemically 
competent E. coli TunerTM(DE3)pLysS cells (Novagen, Darmstadt, Germany). The proteins were 
expressed in Terrific Broth (24% Tryptone (Oxoid, Hampshire, UK), 42% Yeast extract (BD), 4% 
glycerol, 0.72 M Na2HPO4, 0.16 M NaH2PO4) and the protein expression was induced with 0.5 mM 
isopropyl β-D-thiogalactopyranoside (IPTG, Promega, Madison, WI, USA) [22]. The E. coli cells were 
lysed by sonication in a lysis buffer (pH 7.4) containing 20 mM NaPO4, 0.5 M NaCl,  
20 mM Imidazole, 1 mg/mL lysozyme (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 
protease-inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA). The supernatant was then loaded on 
a Cobalt-affinity column (His GraviTrap; GE Healthcare, Brussels, Belgium). The column was washed 
with buffer (20 mM NaPO4, 0.5 M NaCl) containing 40 mM Imidazole and the histidine-tagged 
proteins were eluted from the column with buffer containing 0.3 M imidazole. The eluted proteins 
were dialyzed against phosphate-buffered saline (PBS—137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4; pH 7.4) overnight at 4 °C. Protein concentrations were determined with the Pierce BCA 
protein Assay (Thermo Scientific, Waltham, MA, USA) using bovine serum albumin (Sigma-Aldrich,  
St. Louis, MO, USA) as a standard. Protein purity was analyzed by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) with Coomassie Brilliant Blue Staining (Sigma-Aldrich, St. Louis, 
MO, USA). PageRuler Unstained Protein Ladder (Thermo Scientific, Waltham, MA, USA) was used 
as a protein standard. 
Perfringolysin Antibody ELISA 
A direct ELISA was developed to detect antibodies against perfringolysin in serum samples. 
Immunoplates (Nunc-Immunoplate Polysorp) were coated with 20 μg/mL of purified perfringolysin 
diluted in carbonate buffer (pH 9.5) and incubated overnight at 4 °C. After washing the plates with 
phosphate-buffered saline (PBS) containing 0.1% Tween 20 (Washing Buffer, WB), test and control 
sera diluted in PBS containing 0.05% Tween 20 (Dilution Buffer, DB) were added to the plates and 
incubated for 1 h at 37 °C. The plates were washed between steps with WB, pH 7.4. A hyperimmune 
serum from vaccinated calves diluted in 1:100,000 DB was used as positive control. Testsera and negative 
control serum from a neonatal calf deprived of colostrum were diluted 1:50. All serum dilutions were 
performed in duplicate. The plates were incubated for 2 h at 37 °C with the sera and subsequently 
incubated for 1.5 h at 37 °C conjugated with α bovine horseradish peroxidase (HRP), diluted 1:30,000, 
and again incubated for 1.5 h at 37 °C. The reaction was developed with 3,3′,5,5′-Tetramethylbenzidine 
(TMB; Sigma–Aldrich, St. Louis, MO, USA) as chromogen substrate and the intensity of staining was 
read at 450 nm after 30 min of incubation. All reagents were purchased from Sigma–Aldrich, St. Louis, 
MO, USA. The perfringolysin antibody ELISA was only done on samples from BB beef and veal. 
3.1.4. Statistics 
To determine the effect of breed and production system (beef vs. veal) on alpha toxin ELISA 
inhibition percentage and perfringolysin ELISA optical density, a linear mixed model with repeated 
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measurements was used (PROC MIXED). Sampling point was added as the repeated effect and herd as 
a random effect to account for clustering of calves within a herd. Test variables were breed (BB, HF, 
or crossbred) and production system (beef vs. veal). Pairwise comparisons of significant main effects 
were made using Bonferroni corrections. Significance was set at p < 0.05. All analyses were done in 
SAS 9.4 (SAS Institute, Cary, NC, USA). 
3.2. Study 2: Effect of Solid Feed Intake on Alpha Toxin and Perfringolysin Antibody Dynamics 
3.2.1. Study Design 
A longitudinal experimental cohort study to determine the effect of solid feed intake on 
perfringolysin and alpha toxin antibody dynamics in Holstein Friesian veal calves was conducted 
between May 2014 and November 2014. To detect a difference of 25% in calves that are seropositive 
against alpha toxin with 95% confidence and 80% power, a sample size of 12 calves per group was 
necessary. A total of 15 calves per group were sampled to account for possible mortality. Serum samples 
were taken at the age of 2, 8, 14 and 26 weeks. Calves were weighed at the age of 2 and 26 weeks. 
3.2.2. Animals, Housing and Feeding 
The trial was performed at a commercial veal fattening unit. Thirty male HF calves were randomly 
assigned to one of two treatment groups at the day of arrival at two weeks of age. All calves were kept 
on slatted floor without bedding. Both groups were fed the same amount of milk replacer (21.2% crude 
protein, 17.7% crude fat at dry mater base; Nillproduct, Vilatca nv, Geel, Belgium) in the same concentration, 
twice a day. At the age of two weeks the calves were fed 220 g MR/feeding, increasing to  
1260 g/feeding at the age of 26 weeks. Group 2 also received increasing amounts (32 to 710 g/feeding) 
of commercial veal solid feed (a mixture of barley, corn, spelt and 10% straw; ash 2.4%, crude protein 
9.6%, crude fat 2.9%, crude fiber 8%) twice daily. The vaccination status of the dams was unknown. 
3.2.3. Laboratory Analysis 
Alpha toxin and perfringolysin antibody ELISAs were performed on all samples as described above. 
3.2.4. Statistics 
The effect of the treatment group (solid feed or not) on alpha toxin ELISA % inhibition and 
perfringolysin antibody ELISA OD was determined by a repeated measurements linear mixed model 
(PROC MIXED) as described above, but without a random effect. 
4. Conclusions 
This study explored antibody dynamics for alpha toxin and perfringolysin in beef and veal calves.  
A significant difference in the antibody production for alpha toxin, but not for perfringolysin was 
observed between veal and beef calves. In beef calves a fluent transition from maternal to active 
immunity for alpha toxin was observed, whereas in veal calves on a traditional all-liquid diet a 
significant decline of alpha toxin antibodies was noted. Breed did not influence the antibody dynamics. 
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These observations indicate that dynamics of alpha toxin antibodies may influence the occurrence of 
enterotoxaemia in calves. 
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